(Q74000615)
English
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 r
scientific article published on 01 July 2000
Statements
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it (English)
F Boccardo
A Rubagotti
D Amoroso
M Mesiti
D Romeo
P Sismondi
M Giai
F Genta
P Pacini
V Distante
A Bolognesi
D Aldrighetti